MicroRNA-33a disturbs influenza A virus replication by targeting ARCN1 and inhibiting viral ribonucleoprotein activity.
In order to explore the roles of microRNA(s) [miRNA(s)] in the influenza A virus life cycle, we compared the miRNA profiles of 293T and HeLa cell lines, as influenza A virus can replicate efficiently in 293T cells but only poorly in HeLa cells. We analysed differentially expressed miRNAs and identified five, including miR-33a, that could disturb influenza A virus replication significantly. Using TargetScan analysis, we found that ARCN1 could be a potential target of miR-33a. To confirm whether miR-33a could truly target ARCN1, we generated a luciferase reporter for the ARCN1 3' untranslated region (UTR) and performed a luciferase assay. The data indicated that miR-33a could suppress the luciferase activity of the reporter for the ARCN1 3' UTR but not a reporter in which the predicted miR-33a targeting sites on ARCN1 3' UTR were mutated. We performed immunoblotting to confirm that miR-33a could downregulate the protein level of ARCN1. Consistently, the level of ARCN1 protein in HeLa cells was significantly lower than that in 293T cells. We also demonstrated that ectopic expression of ARCN1 could partially rescue the inhibitory effect of miR-33a on virus replication. Furthermore, we demonstrated that miR-33a could impede virus replication at the stage of virus internalization, which was similar to the pattern for knockdown of ARCN1, indicating that miR-33a inhibits influenza virus infection by suppressing ARCN1 expression. In addition, we found that miR-33a could also weaken the viral ribonucleoprotein activity in an ARCN1-independent manner. In conclusion, we found that miR-33a is a novel inhibitory factor for influenza A virus replication.
Center for Molecular Immunology, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, PR China.
Yi
Y
Hu
Graduate University of Chinese Academy of Sciences, , Beijing 100101, PR China.
Liangzhen
L
Jiang
Graduate University of Chinese Academy of Sciences, , Beijing 100101, PR China.
Wenbin
W
Lai
Graduate University of Chinese Academy of Sciences, , Beijing 100101, PR China.
Yujie
Y
Qin
Graduate University of Chinese Academy of Sciences, , Beijing 100101, PR China.
Tinghong
T
Zhang
Graduate University of Chinese Academy of Sciences, , Beijing 100101, PR China.
Shixiong
S
Wang
Center for Molecular Immunology, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, PR China.
Xin
X
Ye
D019677:Artificial Gene Fusion; D002460:Cell Line; D020756:Coatomer Protein / Q000037:antagonists & inhibitors*; D020869:Gene Expression Profiling; D017930:Genes, Reporter; D054884:Host-Pathogen Interactions; D006801:Humans; D015151:Immunoblotting; D009980:Influenza A virus / Q000276:immunology* / Q000502:physiology*; D008156:Luciferases / Q000032:analysis / Q000235:genetics; D035683:MicroRNAs / Q000378:metabolism*; D012261:Ribonucleoproteins / Q000037:antagonists & inhibitors*; D053586:Virus Internalization
D020756:Coatomer Protein; C550416:MIRN33a microRNA, human; D035683:MicroRNAs; D012261:Ribonucleoproteins; D008156:Luciferases